US Bancorp DE lowered its position in AmerisourceBergen Corp. (NYSE:ABC) by 6.6% in the 4th quarter, HoldingsChannel reports. The fund owned 102,269 shares of the company’s stock after selling 7,266 shares during the quarter. US Bancorp DE’s holdings in AmerisourceBergen were worth $9,390,000 as of its most recent SEC filing.
Several other large investors have also recently made changes to their positions in ABC. Vantage Investment Advisors LLC bought a new position in AmerisourceBergen during the 4th quarter valued at approximately $156,000. Intl Fcstone Inc. bought a new position in AmerisourceBergen during the 2nd quarter valued at approximately $201,000. TRUE Private Wealth Advisors bought a new position in AmerisourceBergen during the 4th quarter valued at approximately $203,000. Zeke Capital Advisors LLC bought a new position in AmerisourceBergen during the 3rd quarter valued at approximately $210,000. Finally, Roberts Glore & Co. Inc. IL bought a new position in AmerisourceBergen during the 3rd quarter valued at approximately $219,000. 67.57% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts recently weighed in on ABC shares. Leerink Swann set a $105.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a research report on Tuesday, January 2nd. Goldman Sachs Group raised AmerisourceBergen from a “neutral” rating to a “buy” rating in a research report on Friday, December 15th. Cowen set a $107.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a research report on Tuesday, December 12th. Deutsche Bank started coverage on AmerisourceBergen in a research report on Monday, December 4th. They set a “buy” rating and a $97.00 price objective for the company. Finally, Robert W. Baird set a $99.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a research report on Friday, December 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $100.67.
Shares of AmerisourceBergen Corp. (NYSE:ABC) opened at $94.22 on Thursday. The company has a market capitalization of $19,963.23, a price-to-earnings ratio of 20.31, a price-to-earnings-growth ratio of 1.47 and a beta of 1.02. AmerisourceBergen Corp. has a fifty-two week low of $71.90 and a fifty-two week high of $106.27. The company has a quick ratio of 0.48, a current ratio of 0.95 and a debt-to-equity ratio of 1.48.
AmerisourceBergen (NYSE:ABC) last posted its earnings results on Tuesday, February 6th. The company reported $1.55 EPS for the quarter, topping the Zacks’ consensus estimate of $1.35 by $0.20. The business had revenue of $40.47 billion during the quarter, compared to analyst estimates of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.36 EPS. sell-side analysts expect that AmerisourceBergen Corp. will post 6.56 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be issued a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.61%. AmerisourceBergen’s payout ratio is 32.76%.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://sportsperspectives.com/2018/02/08/us-bancorp-de-decreases-stake-in-amerisourcebergen-corp-abc.html.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.